1. Home
  2. KRNT vs DBVT Comparison

KRNT vs DBVT Comparison

Compare KRNT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kornit Digital Ltd.

KRNT

Kornit Digital Ltd.

HOLD

Current Price

$13.90

Market Cap

595.3M

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$18.40

Market Cap

508.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNT
DBVT
Founded
2002
2002
Country
Israel
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
595.3M
508.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
KRNT
DBVT
Price
$13.90
$18.40
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$19.75
$19.04
AVG Volume (30 Days)
467.7K
452.4K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$210,041,000.00
$5,502,000.00
Revenue This Year
$3.86
$1,768.71
Revenue Next Year
$2.57
$1,028.88
P/E Ratio
N/A
N/A
Revenue Growth
5.17
N/A
52 Week Low
$11.93
$2.74
52 Week High
$34.29
$21.50

Technical Indicators

Market Signals
Indicator
KRNT
DBVT
Relative Strength Index (RSI) 54.74 71.05
Support Level $13.70 $12.75
Resistance Level $14.63 $21.50
Average True Range (ATR) 0.46 1.17
MACD 0.13 0.70
Stochastic Oscillator 63.65 68.34

Price Performance

Historical Comparison
KRNT
DBVT

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: